AKSHATA UDYAVAR
Company: Actym Therapeutics Inc.
Job title: Senior Director - Immunology & Translational Sciences
Seminars:
ACTM-838: A Novel Microbial Modality That Safely Enriches in TME After IV Dosing & Comprehensively Reactivates the Immunosuppressive TME for a Durable Anti-Tumor Immunity 3:15 pm
To view full session details, download the agenda hereRead more
day: Conference Day 1